EBIT at other companies
Other financials
Where this comes from
Calculated from Ocular Therapeutix’s reported figures.
Plus components not separately reported this period.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's EBIT?
- Ocular Therapeutix (OCUL) reported EBIT of -$93.34M in Q1 2026.
- How has Ocular Therapeutix's EBIT changed year-over-year?
- Ocular Therapeutix's EBIT decreased by 46.0% year-over-year, from -$63.92M to -$93.34M.
- What is the long-term trend for Ocular Therapeutix's EBIT?
- Over 4 years (2021 to 2025), Ocular Therapeutix's EBIT has grown at a 36.4% compound annual growth rate (CAGR), from -$78.04M to -$270.02M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.